ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 156

Usefulness of the Stricter Remission Criteria for Assessing the Absence of Subclinical Activity in Rheumatoid Arthritis

María Victoria Martire1, Maritza Manzano2, Diego Puente Trigo2, Vanesa Duarte2, Gloria Crespo2, Leandro Carlevaris Sr.2, Anastasia Secco2, Marta Mamani2, Lida Santiago2 and Lucila Marino Claverie1, 1Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 2Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: rheumatoid arthritis (RA) and ultrasound

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Imaging of Rheumatic Diseases Poster I: Ultrasound, Optical Imaging and Capillaroscopy

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: It has been seen that patients with rheumatoid arthritis (RA) who achieve remission measured by DAS28 persist with subclinical synovitis in hands and toes when evaluated by ultrasound (US). Unfortunately US is not available in every rheumatology center. Recently, strict criteria like the CDAI, SDAI and ACR EULAR Boolean have been proposed. Therefore it would be interesting to know the accuracy of each set of crteria for assessing the absence of sublinical activity. The aim of this study was to evaluate the accuracy of CDAI, SDAI and ACR EULAR Boolean criteria in RA patients using as gold standard the absence of activity detected by US.

Methods: US examination was performed consecutively on 100 patients with RA fulfilling 2010 ACR EULAR criteria and that were in clinical remission (DAS 28-ESR<2.6) for at least 6 month. Then we evaluated if strict criteria were met (CDAI, SDAI, Boolean). A rheumatologist specialized in musculoskeletal US, blinded to clinical activity, performed a systematic evaluation on grayscale and power Doppler technique with multifrequency linear transducer (10-18MHz) in longitudinal and transverse sections. The radiocarpal joint, second and third metacarpophalangeal, second and third proximal interphalangeal in both hands and second to fifth metatarsophalangeal joints were assessed bilaterally. It was considered as a case if absence of grade II-III exudative synovitis and / or Power Doppler II-III using OMERACT‘s definitions was found. We defined controls as the ones with at least one of these signs of activity. We evaluated the sensitivity, specificity, positive likelihood ratio, positive predictive value (PPV) and negative predictive value (NPV).

Results: One hundred US were performed in 1.800 joints of 100 patients. 80% were women (n = 80) and the mean age was 52.7 SD 12 and the mean DAS28-ESR was 2 SD 0,47. There were no differences in age, sex, disease duration, treatment, or rheumatoid factor and anti-citrullinated protein antibodies positivity between patients with ultrasound activity and without it. 22% were receiving biologic therapy and the mean disease duration was 8.5 IQR 5-14 years and the mean duration of remission was 11.3 months SD 6. Of the US screening 58 didn’t have signs of activity and 42 had synovitis and / or PD grade II-III. Table 1 shows the status of activity and Table 2 shows the results.

Table 1 

 

Ultrasound without activity in hands and toes

n (%)

Remission by Boolean ACR/EULAR criteria  n:45

16 (36)

No Remission by Boolean ACR/EULAR criteria n:55

26 (47)

Remission by SDAI n:70

29 (41)

No remission by SDAI n:30

13 (43)

Remission by CDAI n: 62

26 (41) 

No remission by CDAI n:38

16 (42)

Table 2

    

Sensitivity

% (CI 95)

Specificity

% (CI 95)

PPV

% (CI 95)

NPV

% (CI 95)

Positive LR

          Boolean                ACR/EULAR

38 (29-48)

50 (40-60)

36 (26-45)

53 (43-63)

0,8  (0,5-1,2)

CDAI

62 (53-71)

38 (28-47)

42 (32-52)

58 (48-68)

1 (0,8-1,3)

SDAI

69 (60-78)

29 (20-38)

41 (32-51)

57 (47-66)

1 (0,8-1,3)

Conclusion: We found that in this population, which is in remission by DAS28, no one of the three set criteria is of great value for detecting the absence of activity when using US as gold standard.


Disclosure: M. V. Martire, None; M. Manzano, None; D. Puente Trigo, None; V. Duarte, None; G. Crespo, None; L. Carlevaris Sr., None; A. Secco, None; M. Mamani, None; L. Santiago, None; L. Marino Claverie, None.

To cite this abstract in AMA style:

Martire MV, Manzano M, Puente Trigo D, Duarte V, Crespo G, Carlevaris L Sr., Secco A, Mamani M, Santiago L, Marino Claverie L. Usefulness of the Stricter Remission Criteria for Assessing the Absence of Subclinical Activity in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/usefulness-of-the-stricter-remission-criteria-for-assessing-the-absence-of-subclinical-activity-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/usefulness-of-the-stricter-remission-criteria-for-assessing-the-absence-of-subclinical-activity-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology